Challenges in management of a patient with oropharyngeal carcinoma and scleroderma

Nicole C. Schmitt, Jeremy Richmon, Harry Quon, Virginia Steen, Kristine Pietsch, Brandi R. Page

Research output: Contribution to journalArticlepeer-review


Objective: To discuss some of the challenges that can arise in the treatment of patients with oropharyngeal carcinoma and scleroderma, by presenting an illustrative case. Methods: We report a case of a patient with scleroderma who was treated with surgery, radiation and systemic therapy for oropharyngeal squamous cell carcinoma. We also review the literature on treatment of head and neck squamous cell carcinoma (HNSCC) in scleroderma patients. Results: The patient tolerated treatment well, with a typical degree of toxicity and no evidence of recurrence at 3.5 years following adjuvant therapy. Conclusion: Patients with oropharyngeal cancer and scleroderma should be evaluated on a case-by-case basis in conjunction with a rheumatologist to determine the ideal treatment plan. Patients with limited or well-controlled scleroderma may tolerate treatment better than expected based on historical reports in the literature.

Original languageEnglish (US)
Article number100144
JournalOtolaryngology Case Reports
StatePublished - Mar 2020


  • Autoimmune
  • Connective tissue disorder
  • Scleroderma
  • Squamous cell carcinoma
  • Transoral robotic surgery

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Challenges in management of a patient with oropharyngeal carcinoma and scleroderma'. Together they form a unique fingerprint.

Cite this